Item card
Pharmaceutical biotechnology
Some basic information about the module
Cycle of education:
2022/2023
The name of the faculty organization unit:
The faculty Chemistry
The name of the field of study:
Chemical Technology
The area of study:
technical sciences
The profile of studing:
The level of study:
second degree study
Type of study:
past time
discipline specialities :
Chemical analysis in industry and environment, Engineering of polymer materials, Organic and polymer technology , Product and ecological process engineering, Technology of medicinal products
The degree after graduating from university:
Master of Science (MSc)
The name of the module department :
Department of Biochemistry and Bioinformatics
The code of the module:
10531
The module status:
mandatory for the speciality Technology of medicinal products
The position in the studies teaching programme:
sem: 2 / W9 L18 / 3 ECTS / Z
The language of the lecture:
Polish
The name of the coordinator:
Andrzej Łyskowski, PhD, Eng.
The aim of studying and bibliography
The main aim of study:
Presentation of the methods of production as well as application of traditional and modern biopharmaceutics used in patient therapy.
The general information about the module:
The module consists of 15 hours of lectures and 30 hours of laboratory classes.
others:
Aktualne publikacje naukowe z zakresu biotechnologii, farmakologii i biochemii leków.
Bibliography required to complete the module
| 1 | Oliver Kayser | Podstawy biotechnologii farmaceutycznej | Wydawnictwo Uniwersytetu Jagiellońskiego. | 2006 |
Basic requirements in category knowledge/skills/social competences
Formal requirements:
Valid registration for semester.
Basic requirements in category knowledge:
Knowledge of biochemistry, enzymology, microbiology.
Basic requirements in category skills:
Ability to work in a laboratory, the ability to use laboratory equipment and apparatus.
Basic requirements in category social competences:
Ability to work individually and in team.
Module outcomes
| MEK | The student who completed the module | Types of classes / teaching methods leading to achieving a given outcome of teaching | Methods of verifying every mentioned outcome of teaching | Relationships with KEK | Relationships with PRK |
|---|---|---|---|---|---|
| MEK01 | Has knowledge of methods used in the production of biotechnological medicinal compounds. It has established and expanded knowledge of pharmaceutical biotechnology | Lecture | Written test |
K-W02+++ K-U13++ |
P7S-UW P7S-WG |
| MEK02 | Has knowledge of techniques of working with biological material and mastered the basic techniques for working with biological material. It has the ability to work in a team and sense of responsibility for the joint venture. | Laboratory | Entry test, observation of work |
K-W02++ K-U13+++ |
P7S-UW P7S-WG |
| MEK03 | Student is able to identify directions for further learning and practice learning process with a critical assessment of the sources of knowledge | Lecture, laboratory | Written test, written report |
K-U11+++ |
P7S-UW |
The syllabus of the module
| Sem. | TK | The content | realized in | MEK |
|---|---|---|---|---|
| 2 | TK01 | W01-02 | MEK01 MEK03 | |
| 2 | TK02 | W03-04 | MEK01 MEK03 | |
| 2 | TK03 | W05-06 | MEK01 MEK03 | |
| 2 | TK04 | W07-08 | MEK01 MEK03 | |
| 2 | TK05 | W09-10 | MEK01 MEK03 | |
| 2 | TK06 | W11-12 | MEK01 MEK03 | |
| 2 | TK07 | W13-14 | MEK01 MEK03 | |
| 2 | TK08 | W15 | MEK01 MEK03 | |
| 2 | TK09 | L01-06 | MEK02 MEK03 |
The student's effort
| The type of classes | The work before classes | The participation in classes | The work after classes |
|---|---|---|---|
| Lecture (sem. 2) | The preparation for a test:
15.00 hours/sem. |
contact hours:
9.00 hours/sem. |
complementing/reading through notes:
5.00 hours/sem. Studying the recommended bibliography: 5.00 hours/sem. |
| Laboratory (sem. 2) | The preparation for a Laboratory:
4.00 hours/sem. |
contact hours:
18.00 hours/sem. |
Finishing/Making the report:
4.00 hours/sem. |
| Advice (sem. 2) | The preparation for Advice:
2.00 hours/sem. |
The participation in Advice:
2.00 hours/sem. |
|
| Credit (sem. 2) | The preparation for a Credit:
10.00 hours/sem. |
The written credit:
2.00 hours/sem. |
The way of giving the component module grades and the final grade
| The type of classes | The way of giving the final grade |
|---|---|
| Lecture | The note is proportional to the number of points earned during exam and follows criteria of the Regulaminie Studiów. The positive note is achived only when 50% primary points is collected. |
| Laboratory | Pass note is granted to the students who participated in all laboratory exercises, took all the entry tests and presented written report based on performed exercises. |
| The final grade | The final note is an avarage of all notes collected from the module: K=a*wA+c*wC+l*wL (a-lecture coeff., c-tutorial coeff., l-laboratory coeff., w=1,0, w=0,9, w=0,8 receptively for the 1st, 2nd, 3rd attempt). The note is calculated only if all components have been passed. Values of coefficiants are presented to the students during the initial teaching session. |
Sample problems
Required during the exam/when receiving the credit
(-)
Realized during classes/laboratories/projects
(-)
Others
(-)
Can a student use any teaching aids during the exam/when receiving the credit : no
The contents of the module are associated with the research profile yes
| 1 | A. Bocian; A. Łyskowski; B. Marczak | Antimicrobial Peptide Databases as the Guiding Resource in New Antimicrobial Agent Identification via Computational Methods | 2025 |
| 2 | A. Bocian; J. Buczkowicz; E. Ciszkowicz; K. Hus; K. Lecka-Szlachta; A. Łyskowski | Peptyd antybakteryjny oraz jego zastosowanie | 2025 |
| 3 | A. Bocian; J. Buczkowicz; E. Ciszkowicz; K. Hus; K. Lecka-Szlachta; A. Łyskowski | Peptyd antybakteryjny oraz zastosowanie tego peptydu antybakteryjnego | 2025 |
| 4 | E. Ciszkowicz; M. Dżugan; A. Łyskowski; M. Miłek; M. Tomczyk | Selected Polyphenols of Polish Poplar Propolis as a Key Component Shaping Its Antibacterial Properties—In Vitro and In Silico Approaches | 2025 |
| 5 | M. Bauer; A. Bocian; J. Buczkowicz; E. Ciszkowicz; K. Hus; W. Kamysz; K. Lecka-Szlachta; A. Łyskowski; A. Miłoś; D. Neubauer; A. Nieczaj; K. Sikora | AMPEC4: Naja ashei Venom-Derived Peptide as a Stimulator of Fibroblast Migration with Antibacterial Activity | 2025 |
| 6 | M. Dąbrowska; A. Łyskowski; M. Misiorek; Ż. Szymaszek; M. Twardowska; Ł. Uram; S. Wołowiec | Human Embryonic Kidney HEK293 Cells as a Model to Study SMVT-Independent Transport of Biotin and Biotin-Furnished Nanoparticles in Targeted Therapy | 2025 |
| 7 | A. Łyskowski; M. Misiorek; Z. Rauk; Z. Setkowicz; Ż. Szymaszek; M. Twardowska; Ł. Uram; S. Wołowiec | The Importance of Biotinylation for the Suitability of Cationic and Neutral Fourth-Generation Polyamidoamine Dendrimers as Targeted Drug Carriers in the Therapy of Glioma and Liver Cancer | 2024 |
| 8 | M. Dżugan; A. Łyskowski; M. Miłek | Assessing the Antimicrobial Properties of Honey Protein Components through In Silico Comparative Peptide Composition and Distribution Analysis | 2023 |
| 9 | V. Csitkovits; K. Gruber; C. Kratky; B. Kräutler; A. Łyskowski | Structure-Based Demystification of Radical Catalysis by a Coenzyme B12 dependent Enzyme – Crystallographic Study of Glutamate Mutase with Cofactor Homologues | 2022 |
| 10 | K. Chen; Ł. Jaremko; M. Jaremko; A. Łyskowski | Genetic and Molecular Factors Determining Grain Weight in Rice | 2021 |